Merck & Co., Inc. / Merck Sharp & Dohme Corp (MSD)
Industry / private company
Location:
Kenilworth, NJ,
United States (USA) (US)
ISNI: 0000000122600793
ROR: https://ror.org/02891sr49
Show on Map:
Odanacatib treatment affects trabecular and cortical bone in the femur of postmenopausal women: results of a two-year placebo-controlled trial (2015)
Engelke K, Fuerst T, Dardzinski B, Kornak J, Ather S, Genant HK, De Papp A
Journal article
Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers (2014)
Reibis R, Voeller H, Gitt A, Jannowitz C, Halle M, Pittrow D, Hildemann S
Journal article
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength (2014)
Cheung AM, Majumdar S, Brixen K, Chapurlat R, Fuerst T, Engelke K, Dardzinski B, et al.
Journal article
Multispectral Opto-acoustic Tomography (MSOT) of the Brain and Glioblastoma Characterization (2013)
Burton NC, Patel M, Morscher S, Driessen WHP, Claussen J, Beziere N, Jetzfellner T, et al.
Journal article
Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia (2011)
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Van Kan GA, et al.
Journal article